No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs369463750 |
chr11:101451481-101451482 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs553302040 |
chr11:101451575-101451576 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs55893887 |
chr11:101451639-101451640 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs371350536 |
chr11:101451653-101451654 |
Weak transcription Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs115639411 |
chr11:101451748-101451749 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs11224882 |
chr11:101451765-101451766 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs139608807 |
chr11:101451799-101451800 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs189644819 |
chr11:101451830-101451831 |
Active TSS Flanking Active TSS Weak transcription Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs141898268 |
chr11:101451878-101451879 |
Active TSS Flanking Active TSS Weak transcription Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs560587546 |
chr11:101451912-101451913 |
Active TSS Flanking Active TSS Weak transcription Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs529636438 |
chr11:101451926-101451927 |
Active TSS Flanking Active TSS Weak transcription Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs182412332 |
chr11:101451935-101451936 |
Active TSS Flanking Active TSS Weak transcription Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs187017013 |
chr11:101452017-101452018 |
Active TSS Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs73580383 |
chr11:101452043-101452044 |
Active TSS Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
15 |
rs191093197 |
chr11:101452053-101452054 |
Active TSS Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs115199436 |
chr11:101452087-101452088 |
Active TSS Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs180770697 |
chr11:101452154-101452155 |
Active TSS Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs150603612 |
chr11:101452189-101452190 |
Active TSS Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs7120953 |
chr11:101452193-101452194 |
Active TSS Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
20 |
rs568515337 |
chr11:101452202-101452203 |
Bivalent/Poised TSS Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs534163635 |
chr11:101452229-101452230 |
Bivalent/Poised TSS Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs76872332 |
chr11:101452277-101452278 |
Bivalent/Poised TSS Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs7121108 |
chr11:101452331-101452332 |
Bivalent/Poised TSS Active TSS Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
24 |
rs112238722 |
chr11:101452355-101452356 |
Bivalent/Poised TSS Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs113878453 |
chr11:101452358-101452359 |
Bivalent/Poised TSS Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs149842790 |
chr11:101452376-101452377 |
Bivalent/Poised TSS Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs558674349 |
chr11:101452390-101452391 |
Bivalent/Poised TSS Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs185594430 |
chr11:101452422-101452423 |
Bivalent/Poised TSS Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs4754781 |
chr11:101452508-101452509 |
Bivalent/Poised TSS Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs76068868 |
chr11:101452527-101452528 |
Bivalent/Poised TSS Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs543947991 |
chr11:101452529-101452530 |
Bivalent/Poised TSS Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs560626186 |
chr11:101452541-101452542 |
Bivalent/Poised TSS Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs529673594 |
chr11:101452548-101452549 |
Bivalent/Poised TSS Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs114916766 |
chr11:101452572-101452573 |
Bivalent/Poised TSS Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs190052505 |
chr11:101452655-101452656 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs532793182 |
chr11:101452662-101452663 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs111343117 |
chr11:101452663-101452664 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs79332914 |
chr11:101452699-101452700 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs183017389 |
chr11:101452762-101452763 |
Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs533064580 |
chr11:101452801-101452802 |
Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs531657891 |
chr11:101452809-101452810 |
Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs75827360 |
chr11:101452845-101452846 |
Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs548729121 |
chr11:101452880-101452881 |
Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs568552451 |
chr11:101452904-101452905 |
Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs534201575 |
chr11:101452913-101452914 |
Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs4754782 |
chr11:101452918-101452919 |
Bivalent/Poised TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Active TSS Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
47 |
rs566659656 |
chr11:101453045-101453046 |
Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs538888708 |
chr11:101453057-101453058 |
Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs558568719 |
chr11:101453107-101453108 |
Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh
|
CpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
50 |
rs147953040 |
chr11:101453128-101453129 |
Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh
|
CpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|